COVID-19: Lessons, Transitions, and Data Pathway

If you're interested in learning more about COVID-19 transitions, lessons, and data, check out these sessions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

Sunday

11002 The Role of Journalism in the Analysis and Dissemination of Pandemic-Related Data Through the Lens of the COVID Tracking Project

The pandemic forced laboratory medicine into the spotlight unlike any other event in modern history. As such, the media became the mouthpiece for the dissemination of most information, both that which was factual and that which was fiction. This special Sunday session illustrates the experience of a journalist whose career quickly pivoted to cover timely breakthroughs related to lab allocation, resulting, and testing. Further, his dual role as a journalist and co-founder of The COVID Tracking Project allowed him unique insight into how to communicate big-data to the country. To this day, The COVID Tracking Project is unsurpassed by any other data repository. Learn more.

Monday

32227 Understanding Adaptive Immune Response to SARS-CoV-2: Applications in Clinical Practice, Public Health, and Vaccine Studies

Through this Scientific Session, we will review the understanding of the adaptive immune response to SARS-CoV-2 and how this has shaped clinical practice, public health decisions, and vaccine studies. Three presentations will explore basic immunology, clinical assessment, and serological and functional assays. Learn more.

12001 or 62002 COVID-19: Vaccines and the Tango of Viral Evolution and Host Immune Responses

SARS-CoV-2 is an RNA virus that easily mutates; mutants that are not suppressed by the immune responses generated from prior infection or vaccination can then become dominant strains. Different types of immune responses have varying efficacy against different strains of a virus. From diseases such as influenza, we know that some antibodies are very strain-specific, while others can neutralize different strains. Vaccines that depend solely on antibody responses either need to be able to neutralize newly arising strains of a virus, or, as is the case with influenza, vaccines need to be remade annually to try to correspond to the current clinical circulating strains. Learn more.

Tuesday

33108 Implementation of Serological and Molecular Tools for COVID-19 Patient Management 

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel virus that causes COVID-19 and has considerable variability in symptom severity and outcomes among infected patients. In early studies, both host and viral genetic factors have identified genetic markers that could explain mechanisms of SARS-CoV-2 infection and severity and also help to identify new targets for vaccine development, therapeutics, and patient management. Learn more.

Wednesday

14001 or 64001 Curating and Documenting Research During Chaos: Lessons from COVID-19 and Beyond 

The COVID-19 pandemic led to enormous scientific progress in a short time. The development of the vaccines and the understanding of the virus happened at unprecedented rates and with great success. However, the effects of the pandemic have been dramatic on the scientific workforce, on the speed with which publishing has occurred, and on the ability to build public trust in science. The Editor-in-Chief of the Science family of journals has an unusual perspective on this since outstanding research flows through the journals but also because the news and commentary sections of Science deal with the communications and policy arena. The scientific community needs to come together to face the enormous challenges posed by the need for greater trust in science in the public in the U.S. and beyond. Learn more.

Thursday

35108 What COVID-19 Testing Hath Wrought: A Forecast for the Future of Virology Testing 

COVID-19 has been like no other analyte in the clinical laboratory. This Scientific Session will explore how COVID-19 has changed clinical laboratories in the last year and how we think it will change clinical laboratories going forward. Learn more.

No model set

   at Glass.Mapper.Sc.GlassHtml.MakeEditable[T](Expression`1 field, Expression`1 standardOutput, T model, Object parameters, Context context, Database database, TextWriter writer) in c:\TeamCity\buildAgent\work\8567e2ba106d3992\Source\Glass.Mapper.Sc\GlassHtml.cs:line 539

No model set

   at Glass.Mapper.Sc.GlassHtml.MakeEditable[T](Expression`1 field, Expression`1 standardOutput, T model, Object parameters, Context context, Database database, TextWriter writer) in c:\TeamCity\buildAgent\work\8567e2ba106d3992\Source\Glass.Mapper.Sc\GlassHtml.cs:line 539